Word: beecham
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...year, watch for heavy lobbying for the granddaddy of all patent extenders. It would protect pharmaceutical company sales of $3 billion annually and add years to the profitable life of at least seven expensive drugs, such as Schering-Plough's Claritin for allergies and Eulexin for prostate cancer, SmithKline Beecham's Relafen for arthritis and G.D. Searle's Daypro for arthritis. The big losers: patients, especially senior citizens on fixed incomes, who must buy expensive prescription drugs instead of cheaper generic versions. Estimates of the added cost run from $1 billion to $11 billion over the next decade...
...future is upon us. The medical industry took another step forward Monday when Glaxo Wellcome announced a $76 billion acquisition of SmithKline Beecham, creating yet another "world's largest pharmaceuticals company". As drugmakers jockey for position in the pending biomedical revolution, the recent merger frenzy has seen the largest firms consolidating and branching into two distinct arms - core businesses, which maintain funding streams, and research and development, which positions the firms for the next century. The SmithKline acquisition gives Glaxo one of the world's largest troves of biomed brainpower and a combined $25 billion in annual revenues...
...years Cuba's communist dictator, Fidel Castro, has chafed, rattled and raged under the cold-war headlock of a U.S. trade embargo. But this past summer the wily presidente sensed an opening. Philadelphia health-care-products giant SmithKline Beecham (a subsidiary of SmithKline Beecham in Britain) got the Clinton Administration's O.K. to pay Cuba some $20 million for the rights to test and market, in the U.S., a meningitis vaccine developed by Cuban scientists. Embargo rules still require SmithKline to pay initially in barter instead of dollars--a Yanqui condition that aides expected Castro to reject. To their surprise...
...Paxil and its manufacturer, SmithKline Beecham, are upping the ante. If the FDA agrees, and it probably will, SmithKline will soon be pushing Paxil as the first-ever formally sanctioned treatment for, of all things, shyness. This isn't as bizarre as it sounds. FDA approval would actually be for the treatment of "acute social phobia," a pathological form of shyness that's more akin to panic. For doctors, at least, it's no surprise that phobia and depression might be treated with the same drugs. "The big secret," says Dr. Brian Doyle, director of the anxiety disorders program...
Manufactured by SmithKline Beecham under the brand name Lymerix, the new vaccine operates on the principle that the best defense is a good offense. Unlike other vaccines, it targets disease-causing organisms outside the body, in the tick, rather than after they've invaded the bloodstream. Here's how it works...